Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (8)

2019

  1. Prevalence of fatigue and impact on quality of life in castration-resistant prostate cancer patients: The Vital study

    BMC Urology, Vol. 19, Núm. 1

2018

  1. Efficacy and safety of a hexanic extract of Serenoa repens (Permixon®) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies

    BJU International, Vol. 122, Núm. 6, pp. 1049-1065

2017

  1. Diagnosis and treatment for clinically localized prostate cancer. Adherence to the European Association of Urology clinical guidelines in a nationwide population-based study – GESCAP group

    Actas Urologicas Espanolas, Vol. 41, Núm. 6, pp. 359-367

  2. The presence of pretransplant antiphospholipid antibodies iga anti-b-2-glycoprotein i as a predictor of graft thrombosis after renal transplantation

    Transplantation, Vol. 101, Núm. 3, pp. 597-607

2016

  1. Tendencias de tratamiento en el cáncer de próstata clínicamente localizado. Análisis poblacional a nivel nacional: grupo GESCAP

    Actas Urologicas Espanolas, Vol. 40, Núm. 4, pp. 209-216

2013

  1. Perfiles de severidad en pacientes diagnosticados de hiperplasia benigna prostática en España

    Actas Urologicas Espanolas, Vol. 37, Núm. 9, pp. 544-548

  2. Registro nacional de cáncer de próstata 2010 en España

    Actas Urologicas Espanolas, Vol. 37, Núm. 1, pp. 12-19

2012

  1. Prostate cancer incidence and newly diagnosed patient profile in Spain in 2010

    BJU International, Vol. 110, Núm. 11 B